Bought in today after researching over the break. It is really rare to find a biotech company with so much established, non-sponsored medical literature behind their products. The studies on the acne treatment is very interesting. As an early days product can see this being scaled up to provide a real, side-effect free alternative to what's currently on the market.
Rising prevalence of minor, but persistent MRSA infections a huge treatment opportunity as well. Exciting times.
IPO - Next Science Limited, page-124
-
- There are more pages in this discussion • 93 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NXS (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
23.5¢ |
Change
0.010(4.44%) |
Mkt cap ! $68.54M | |||
| Open | High | Low | Value | Volume |
| 22.0¢ | 23.5¢ | 21.5¢ | $46.14K | 206.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 130676 | 21.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 23.5¢ | 19533 | 2 |
View Market Depth
| Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
| NXS (ASX) Chart |